title: Hereditary hemochromatosis: insights from the Hemochromatosis and Iron Overload Screening (HEIRS) Study.
abstract: Hemochromatosis comprises a group of inherited disorders resulting from mutations of genes involved in regulating iron metabolism. The multicenter, multi-ethnic Hemochromatosis and Iron Overload Screening (HEIRS) Study screened approximately 100,000 participants in the US and Canada, testing for HFE mutations, serum ferritin and transferrin saturation. As in other studies, HFE C282Y homozygosity was common in Caucasians but rare in other ethnic groups, and there was a marked heterogeneity of disease expression in C282Y homozygotes. Nevertheless, this genotype was often associated with elevations of serum ferritin and transferrin saturation and with iron stores of more than four grams in men but not in women. If liver biopsy was performed, in some cases because of evidence of hepatic dysfunction, fibrosis or cirrhosis was often found. Combined elevations of serum ferritin and transferrin saturation were observed in non-C282Y homozygotes of all ethnic groups, most prominently Asians, but not often with iron stores of more than four grams. Future studies to discover modifier genes that affect phenotypic expression in C282Y hemochromatosis should help identify patients who are at greatest risk of developing iron overload and who may benefit from continued monitoring of iron status to detect progressive iron loading.
authors.affiliation: Veterans Affairs Long Beach Healthcare System, Long Beach, CA 90822, USA. gordon.mclaren@va.gov
authors.forename: Gordon D
authors.initials: GD
authors.lastname: McLaren
authors.forename: Victor R
authors.initials: VR
authors.lastname: Gordeuk
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D023181:Antimicrobial Cationic Peptides / Q000172:deficiency / Q000235:genetics / Q000502:physiology; D002170:Canada / Q000453:epidemiology; D005006:Ethnicity / Q000235:genetics; D005260:Female; D005293:Ferritins / Q000097:blood; D018740:Genetic Heterogeneity; D005838:Genotype; D006432:Hemochromatosis / Q000453:epidemiology / Q000208:ethnology / Q000235:genetics* / Q000473:pathology; D000071020:Hemochromatosis Protein; D064451:Hepcidins; D015395:Histocompatibility Antigens Class I / Q000235:genetics*; D006801:Humans; D007408:Intestinal Absorption / Q000235:genetics / Q000502:physiology; D007501:Iron / Q000097:blood; D019190:Iron Overload / Q000209:etiology / Q000517:prevention & control; D019266:Iron, Dietary / Q000493:pharmacokinetics; D008099:Liver / Q000473:pathology; D008297:Male; D008403:Mass Screening / Q000706:statistics & numerical data*; D008565:Membrane Proteins / Q000235:genetics*; D008875:Middle Aged; D020125:Mutation, Missense; D017354:Point Mutation; D015995:Prevalence; D012727:Sex Characteristics; D014168:Transferrin / Q000032:analysis; D014481:United States / Q000453:epidemiology
chemical_list: D023181:Antimicrobial Cationic Peptides; C103673:HFE protein, human; D000071020:Hemochromatosis Protein; D064451:Hepcidins; D015395:Histocompatibility Antigens Class I; D019266:Iron, Dietary; D008565:Membrane Proteins; D014168:Transferrin; D005293:Ferritins; D007501:Iron